Literature DB >> 21988991

Tuberculosis vaccine promises sterilizing immunity.

Helen McShane, Ann Williams.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21988991     DOI： 10.1038/nm.2503

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  11 in total

1.  The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs.

Authors:  Carlos Martin; Ann Williams; Rogelio Hernandez-Pando; Pere J Cardona; Eamonn Gormley; Yann Bordat; Carlos Y Soto; Simon O Clark; Graham J Hatch; Diana Aguilar; Vicente Ausina; Brigitte Gicquel
Journal:  Vaccine       Date:  2006-04-24       Impact factor: 3.641

2.  A multistage tuberculosis vaccine that confers efficient protection before and after exposure.

Authors:  Claus Aagaard; Truc Hoang; Jes Dietrich; Pere-Joan Cardona; Angelo Izzo; Gregory Dolganov; Gary K Schoolnik; Joseph P Cassidy; Rolf Billeskov; Peter Andersen
Journal:  Nat Med       Date:  2011-01-23       Impact factor: 53.440

3.  Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.

Authors:  Helen McShane; Ansar A Pathan; Clare R Sander; Sheila M Keating; Sarah C Gilbert; Kris Huygen; Helen A Fletcher; Adrian V S Hill
Journal:  Nat Med       Date:  2004-10-24       Impact factor: 53.440

4.  Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns.

Authors:  Benjamin M N Kagina; Brian Abel; Thomas J Scriba; Elizabeth J Hughes; Alana Keyser; Andreia Soares; Hoyam Gamieldien; Mzwandile Sidibana; Mark Hatherill; Sebastian Gelderbloem; Hassan Mahomed; Anthony Hawkridge; Gregory Hussey; Gilla Kaplan; Willem A Hanekom
Journal:  Am J Respir Crit Care Med       Date:  2010-06-17       Impact factor: 21.405

5.  Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells.

Authors:  Steven C Derrick; Idalia M Yabe; Amy Yang; Sheldon L Morris
Journal:  Vaccine       Date:  2011-02-21       Impact factor: 3.641

Review 6.  Who puts the tubercle in tuberculosis?

Authors:  David G Russell
Journal:  Nat Rev Microbiol       Date:  2006-12-11       Impact factor: 60.633

7.  A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis.

Authors:  Kari A Sweeney; Dee N Dao; Michael F Goldberg; Tsungda Hsu; Manjunatha M Venkataswamy; Marcela Henao-Tamayo; Diane Ordway; Rani S Sellers; Paras Jain; Bing Chen; Mei Chen; John Kim; Regy Lukose; John Chan; Ian M Orme; Steven A Porcelli; William R Jacobs
Journal:  Nat Med       Date:  2011-09-04       Impact factor: 53.440

8.  Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness.

Authors:  B Bourdin Trunz; Pem Fine; C Dye
Journal:  Lancet       Date:  2006-04-08       Impact factor: 79.321

Review 9.  The second Geneva Consensus: Recommendations for novel live TB vaccines.

Authors:  K B Walker; M J Brennan; M M Ho; J Eskola; G Thiry; J Sadoff; R Dobbelaer; L Grode; M A Liu; U Fruth; P H Lambert
Journal:  Vaccine       Date:  2010-01-20       Impact factor: 3.641

10.  Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans.

Authors:  Troy D Querec; Rama S Akondy; Eva K Lee; Weiping Cao; Helder I Nakaya; Dirk Teuwen; Ali Pirani; Kim Gernert; Jiusheng Deng; Bruz Marzolf; Kathleen Kennedy; Haiyan Wu; Soumaya Bennouna; Herold Oluoch; Joseph Miller; Ricardo Z Vencio; Mark Mulligan; Alan Aderem; Rafi Ahmed; Bali Pulendran
Journal:  Nat Immunol       Date:  2008-11-23       Impact factor: 25.606
View more
  3 in total

1.  Protection against tuberculosis with homologous or heterologous protein/vector vaccine approaches is not dependent on CD8+ T cells.

Authors:  Susan L Baldwin; Lance K Ching; Samuel O Pine; Magdalini Moutaftsi; Elyse Lucas; Aarthy Vallur; Mark T Orr; Sylvie Bertholet; Steven G Reed; Rhea N Coler
Journal:  J Immunol       Date:  2013-07-31       Impact factor: 5.422

2.  A novel class of antimicrobial drugs selectively targets a Mycobacterium tuberculosis PE-PGRS protein.

Authors:  Hoonhee Seo; Sukyung Kim; Hafij Al Mahmud; Md Imtiazul Islam; Youjin Yoon; Hyun-Deuk Cho; Kung-Woo Nam; Jiwon Choi; Young Sig Gil; Byung-Eui Lee; Ho-Yeon Song
Journal:  PLoS Biol       Date:  2022-05-31       Impact factor: 9.593

3.  A Web-Based Platform for Designing Vaccines against Existing and Emerging Strains of Mycobacterium tuberculosis.

Authors:  Sandeep Kumar Dhanda; Pooja Vir; Deepak Singla; Sudheer Gupta; Shailesh Kumar; Gajendra P S Raghava
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.